Shree Rasbihari Trading and Investments Private Limited, a promoter entity of Mangalam Drugs & Organics Limited , has announced the release of pledged shares worth 1.09% of the pharmaceutical company's total share capital. The disclosure was submitted to stock exchanges on March 18, 2026, in compliance with SEBI regulations.

Share Release Details

The promoter released 1,73,000 shares that were previously pledged as security for debt arrangements. These shares represent 1.09% of Mangalam Drugs & Organics Limited's total share capital and were encumbered in favor of M/s Famycare Private Ltd.

Promoter Shareholding Position

Following the release of pledged shares, Shree Rasbihari Trading maintains its overall shareholding position in the target company without any remaining encumbrances.

Regulatory Compliance

The disclosure was made pursuant to Regulations 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The notification was simultaneously submitted to both BSE Limited (Scrip Code: 532637) and National Stock Exchange of India Limited (Symbol: MANGALAM), where Mangalam Drugs & Organics Limited shares are listed.

Corporate Information

Shree Rasbihari Trading and Investments Private Limited operates under CIN U65990MH1981PTC024001 with its registered office located at Marine Drive, Mumbai. The disclosure was signed by Director Smita A. Dhoot (DIN: 01867999), who digitally authenticated the submission on March 18, 2026.

The release of these pledged shares indicates the completion of the underlying debt arrangement that necessitated the original encumbrance, providing the promoter with full flexibility over its entire shareholding in the pharmaceutical company.

Mangalam Drugs & Organics Limited announced significant board-level changes following a meeting held on February 6, 2026. The company's Board of Directors addressed key leadership transitions, including a director resignation, new CFO appointment, and director re-appointment during the session that lasted from 12:00 P.M. to 2:25 P.M.

Director Resignation and Transition

The board formally accepted the resignation of Shri Rukmesh P. Dhandhania from his position as Independent Director, effective January 16, 2026. In his resignation letter dated January 16, 2026, Dhandhania cited his decision to retire from professional responsibilities after years of committed service to the institution. His departure also resulted in his cessation from membership of the Audit Committee and Nomination and Remuneration Committee.

New Chief Financial Officer Appointment

The board approved the appointment of Mr. Jeevan Mukund Dalvi as Chief Financial Officer and Key Managerial Personnel, effective February 6, 2026. Dalvi brings over two decades of experience in accounts and finance to his new role. His expertise includes financial advisory, cost saving measures, and improving financial processes of the company.

Independent Director Re-appointment

The board considered and approved the re-appointment of Dr. Praveen Saxena as Independent Director for a second term of five years, from March 21, 2026, to March 20, 2031. This re-appointment is subject to shareholder approval through a Special Resolution.

Dr. Saxena brings extensive international expertise in energy policy and renewable energy sectors. He has been recognized with the International Business Leadership Innovation Excellence Award by the Institute of Economic Studies, Government of Malaysia in 2017. His credentials include over 50 research publications in international journals, leadership experience in energy policy formulation, strategic oversight of solar and small hydro programs, and international representation of India's renewable energy interests.

Regulatory Compliance and Communication

All announcements were made in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015. The company has formally communicated these changes to both BSE Limited (Scrip Code: 532637) and National Stock Exchange of India Limited (Symbol: MANGALAM) through official correspondence dated February 6, 2026.

The communication was signed by Govardhan M. Dhoot, Chairman & Managing Director (DIN: 01240086), and includes detailed annexures with complete profiles and regulatory disclosures for each appointment and resignation as required under listing regulations.